Fundraising Fox

Atlas Oncology Holdings Inc.

Nashville, US · Founded 2023 · Delaware corporation · 1 known investors

Founders & leadership

DG
David GlaccumNamed on SEC filing
TN
Todd NiceNamed on SEC filing
KB
Kate Barnard RobertsNamed on SEC filing

Board

MK
Matt KimBoard director
ICIan Chiang
Ian Chiangin𝕏Board directorPartner at Flare Capital Partners
TSTara Sullivan
Tara SullivaninBoard directorPrincipal at Flare Capital Partners
DF
Dave FieldingBoard director

Investors · 1

Flare Capital PartnersreportedBoston · $1M – $10Mvia Ian Chiang · board

Reported raises · per SEC filings

Form D private placements

$23M disclosed across 1 round · 2026

▶$23MraisedFeb 2026 · 3 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Matt KimDirector, Promoter
  • David GlaccumExecutive Officer, Director, Promoter
  • Ian ChiangDirector
  • Todd NiceExecutive Officer, Promoter
  • Kate Barnard RobertsExecutive Officer, Promoter
  • Tara SullivanDirector
  • Dave FieldingDirector, Promoter
Offering amount
$23M
Amount sold
$23M
First sale
Feb 2026
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Atlas Oncology Holdings Inc.'s investors?
Atlas Oncology Holdings Inc.'s investors include Flare Capital Partners.
How much funding has Atlas Oncology Holdings Inc. raised?
Atlas Oncology Holdings Inc. has disclosed $23M raised across 1 round.
Where is Atlas Oncology Holdings Inc. headquartered?
Atlas Oncology Holdings Inc. is headquartered in Nashville, US.